Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
NEWARK, N.Y., Oct. 02, 2017 -- Ultralife Corporation (NASDAQ:ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $49.8 million from the U.S. Government’s Defense Logistic Agency (DLA) for its hybrid lithium manganese dioxide/carbon monofluoride (CFx) non-rechargeable BA-5790 and BA-5795 batteries. The award is for five years with the amounts and timing of deliveries at the discretion of the DLA. Initial deliveries under this contract are expected to begin by the first quarter of 2019.
“Ultralife is a long-standing supplier to the U.S. military focused on the continued development of new products to meet the ongoing needs of the warfighter. Building on the success of our existing lithium manganese dioxide family of primary batteries, our new CFx batteries deliver 1.5 times the energy in the same size and weight as our legacy batteries making them ideal for longer duration missions, while maintaining our proven safety, performance and reliability under the toughest of conditions,” said Michael D. Popielec, President and Chief Executive Officer.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
Company Contact:
Ultralife Corporation
Philip A. Fain
(315) 210-6110
[email protected]
Investor Relations Contact:
LHA
Jody Burfening
(212) 838-3777
[email protected]
